[Associated Press] Medical Groups Question Price Of New Hep C Drug

By Matthew Perrone

March 11, 2014

An innovative hepatitis C drug that was only recently hailed as a breakthrough treatment is facing skepticism from some health care providers, as they consider whether it is worth the $1,000-a-pill price set by manufacturer Gilead Sciences Inc.